We're commencing a two-part Special Episode of Dialogues on AI Digital Pathology!
This episode brings together our guests, Key Opinion Leaders in liver pathology, who will be speaking about the key takeaways from the recent FDA webcast on NASH Drug Development, and responding to questions from the industry on designing clinical trial strategies with AI digital pathology. Here's a Trailer of Part 1 with snippets from Professor Pierre Bedossa, Professor Zachary Goodman, and Professor David Kleiner as they speak to our Moderator, Dr Nikolai Naoumov.
Guests
Prof. Pierre Bedossa
Professor of Pathology at the University of Paris; Consultant in Liver Pathology at LIVERPAT, Paris, France.
Prof. Zachary Goodman
Director of Hepatic Pathology Consultation and Research, Inova Fairfax Hospital, Falls Church, Virginia, USA.
Prof. David Kleiner
Senior Research Physician and Chief of Post-mortem Section, Laboratory of Pathology, Center for Cancer Research,
National Cancer Institute, Bethesda, Maryland, USA.
Moderator
Dr. Nikolai Naoumov
Adviser for Clinical Research and Drug Development in Liver Diseases, Novartis Pharma AG
